Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Sue Hughes

News

Oral PCSK9 inhibitor shows encouraging LDL lowering

Author:
Sue Hughes
Publish date: March 16, 2023

A new oral formulation of a PCSK9-inhibiting cholesterol-lowering drug has shown encouraging results in a phase 2 study.

  • Read More

News

Endurance exercise tied to more coronary atherosclerosis

Author:
Sue Hughes
Publish date: March 13, 2023

Lifelong endurance athletes had more coronary plaques, including more noncalcified plaques, than fit and healthy individuals, according to a new...

  • Read More

News

Encouraging 3-year data for TAVR in low-risk patients: EVOLUT

Author:
Sue Hughes
Publish date: March 8, 2023

The 3-year results show that low-surgical-risk patients undergoing aortic valve replacement continue to show lower rates of all-cause mortality...

  • Read More

News

‘Keto-like’ diet linked to doubling of heart disease risk

Author:
Sue Hughes
Publish date: March 8, 2023

But one lipid expert has highlighted limitations of the observational study and advised caution in interpreting the results.

  • Read More

News

BIOVASC: Immediate complete revascularization beneficial in ACS

Author:
Sue Hughes
Publish date: March 5, 2023

Immediate complete revascularization during the index procedure might become the new treatment paradigm in patients with ACS and multivessel...

  • Read More

News

Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes

Author:
Sue Hughes
Publish date: March 4, 2023

The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...

  • Read More

News

New AHA statement urges focus on CV risk before pregnancy

Author:
Sue Hughes
Publish date: February 28, 2023

The emphasis on reducing cardiovascular risk during pregnancy comes too late – the risks have already developed in these patients.

  • Read More

News

Similar effect of early, late BP reduction in stroke: CATIS-2

Author:
Sue Hughes
Publish date: February 17, 2023

“Antihypertensive treatment can be delayed for at least 7 days following ischemic stroke onset, unless there are severe acute comorbidities that...

  • Read More

News

Thrombolysis not necessary in mild nondisabling stroke: ARAMIS

Author:
Sue Hughes
Publish date: February 17, 2023

‘We may be doing more harm than good with alteplase in this patient population,’ says expert.

  • Read More

News

Drug combo promising in vascular cognitive impairment: LACI-2 trial results

Author:
Sue Hughes
Publish date: February 16, 2023

The drugs – isosorbide monoitrate and cilostazol – stabilize endothelial function, which is a new therapeutic target for patients with small-...

  • Read More

News

Thrombectomy benefits stroke with large core volumes: SELECT2 trial results

Author:
Sue Hughes
Publish date: February 13, 2023

Study findings may change clinical practice and the way in which systems of stroke care are organized.

  • Read More

News

STROKE AF at 3 years: High AFib rate after atherosclerotic stroke

Author:
Sue Hughes
Publish date: February 13, 2023

Continuous monitoring to detect AFib should be considered in a larger population of stroke patients rather than just those with cryptogenic stroke...

  • Read More

News

Brain differences suggest therapeutic targets in Takotsubo

Author:
Sue Hughes
Publish date: January 19, 2023

A new study has identified differences in the brain between patients with Takotsubo syndrome, a cardiomyopathy triggered by intense emotional...

  • Read More

News

Warfarin best for thrombotic antiphospholipid syndrome?

Author:
Sue Hughes
Publish date: January 11, 2023

A vitamin K antagonist such as warfarin, rather than a direct oral anticoagulant, appears to be a better treatment for patients with thrombotic...

  • Read More

News

Is thrombolysis safe for stroke patients on DOACs?

Author:
Sue Hughes

“Our results suggest that current guidelines need to be revised to remove the absolute contraindication of thrombolysis in patients on DOACs.”

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close